| Literature DB >> 33104215 |
Kira Bona1, Ruta Brazauskas2,3, Naya He2, Leslie Lehmann4, Hisham Abdel-Azim5, Ibrahim A Ahmed6, A Samer Al-Homsi7, Mahmoud Aljurf8, Staci D Arnold9, Sherif M Badawy10,11, Minoo Battiwalla12, Sara Beattie13,14, Neel S Bhatt15, Jignesh Dalal16, Christopher E Dandoy17, Miguel Angel Diaz18, Haydar A Frangoul19, César O Freytes20, Siddhartha Ganguly21, Biju George22, David Gomez-Almaguer23, Theresa Hahn24, Rammurti T Kamble25, Jennifer M Knight26, C Fred LeMaistre12, Jason Law27, Hillard M Lazarus28, Navneet S Majhail29, Richard F Olsson30,31, Jaime Preussler32, Bipin N Savani33, Raquel Schears34, Sachiko Seo35, Akshay Sharma36, Alok Srivastava37, Amir Steinberg38, David Szwajcer39, Baldeep Wirk40, Ayami Yoshimi41, Nandita Khera42, William A Wood43, Shahrukh Hashmi44,45, Christine N Duncan4, Wael Saber2.
Abstract
Social determinants of health, including poverty, contribute significantly to health outcomes in the United States; however, their impact on pediatric hematopoietic cell transplantation (HCT) outcomes is poorly understood. We aimed to identify the association between neighborhood poverty and HCT outcomes for pediatric allogeneic HCT recipients in the Center for International Blood and Marrow Transplant Research database. We assembled 2 pediatric cohorts undergoing first allogeneic HCT from 2006 to 2015 at age ≤18 years, including 2053 children with malignant disease and 1696 children with nonmalignant disease. Neighborhood poverty exposure was defined a priori per the US Census definition as living in a high-poverty ZIP code (≥20% of persons below 100% federal poverty level) and used as the primary predictor in all analyses. Our primary outcome was overall survival (OS), defined as the time from HCT until death resulting from any cause. Secondary outcomes included relapse and transplantation-related mortality (TRM) in malignant disease, acute and chronic graft-versus-host disease, and infection in the first 100 days post-HCT. Among children undergoing transplantation for nonmalignant disease, neighborhood poverty was not associated with any HCT outcome. Among children undergoing transplantation for malignant disease, neighborhood poverty conferred an increased risk of TRM but was not associated with inferior OS or any other transplantation outcome. Among children with malignant disease, a key secondary finding was that children with Medicaid insurance experienced inferior OS and increased TRM compared with those with private insurance. These data suggest opportunities for future investigation of the effects of household-level poverty exposure on HCT outcomes in pediatric malignant disease to inform care delivery interventions.Entities:
Mesh:
Year: 2021 PMID: 33104215 PMCID: PMC7845011 DOI: 10.1182/blood.2020006252
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 25.476